The de novo peptide-sequencing method can be used to directly infer the peptide sequence from a tandem mass spectrum. It has the advantage of not relying on protein databases and plays a key role in the determination of the protein sequences of unknown species, monoclonal antibodies, and cancer neoantigens. In this paper, we propose a method based on graph convolutional neural networks and convolutional neural networks, Denovo-GCN, for de novo peptide sequencing. We constructed an undirected graph based on the mass difference between the spectral peaks in a tandem mass spectrum. The features of the nodes on the spectrum graph, which represent the spectral peaks, were the matching information of the peptide sequence and the mass spectrum. Next, the Denovo-GCN used CNN to extract the features of the nodes. The correlation between the nodes was represented by an adjacency matrix, which aggregated the features of neighboring nodes. Denovo-GCN provides a complete end-to-end training and prediction framework to sequence patterns of peptides. Our experiments on various data sets from different species show that Denovo-GCN outperforms DeepNovo with a relative improvement of 13.7–25.5% in terms of the peptide-level recall.
Although data-independent acquisition (DIA) has the ability to identify and quantify all peptides in a sample, highly complex mixed mass spectra present difficulties for accurate peptide and protein identification. Additionally, the correspondence between the precursor and its fragments is broken, making it challenging to perform peptide identification directly using conventional DDA search engines. In this paper, we propose a cosine-similarity-based deconvolution method: CorrDIA. This is achieved by reconstructing the correspondence between precursor and fragment ions based on the consistency of extracted ion chromatograms (XICs). A deisotope peak cluster operation is added and centered on the MS/MS spectrum to improve the accuracy of spectrum interpretation and increase the number of identified peptides. The resulting MS/MS spectra can be identified using any data-dependent acquisition (DDA) sequencing software. The experimental results demonstrate that the number of peptide results increased by 12 percent and 21 percent respectively, and the repetition rate decreased by 12 percent. This reduces mass spectra complexity and difficulties in mass spectra analysis without the need for any mass spectra libraries.